1,618 research outputs found

    Meta‐analysis: rapid infliximab infusions are safe

    Full text link
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/99086/1/apt12389.pd

    Specific heat and high-temperature series of lattice models: interpolation scheme and examples on quantum spin systems in one and two dimensions

    Full text link
    We have developed a new method for evaluating the specific heat of lattice spin systems. It is based on the knowledge of high-temperature series expansions, the total entropy of the system and the low-temperature expected behavior of the specific heat as well as the ground-state energy. By the choice of an appropriate variable (entropy as a function of energy), a stable interpolation scheme between low and high temperature is performed. Contrary to previous methods, the constraint that the total entropy is log(2S+1) for a spin S on each site is automatically satisfied. We present some applications to quantum spin models on one- and two- dimensional lattices. Remarkably, in most cases, a good accuracy is obtained down to zero temperature.Comment: 10 pages (RevTeX 4) including 11 eps figures. To appear in Phys. Rev.

    Low temperature expansion for the 3-d Ising Model

    Full text link
    We compute the weak coupling expansion for the energy of the three dimensional Ising model through 48 excited bonds. We also compute the magnetization through 40 excited bonds. This was achieved via a recursive enumeration of states of fixed energy on a set of finite lattices. We use a linear combination of lattices with a generalization of helical boundary conditions to eliminate finite volume effects.Comment: 10 pages, IASSNS-HEP-92/42, BNL-4767

    Evaluation of the ESBL-coding plasmids transmissibility in E. coli isolated from ambulatory patient's urina

    Get PDF
    Representatives of the Enterobacteriaceae family are the main causative agents of urinary tract infections. Escherichia coli can exhibit resistance to [beta] -lactam antibiotics by synthesizing ESBL (extended spectrum [beta]-lactamases). CTX-M [beta] -lactamases are the dominant group of ESBL. In this paper, we investigated the ability of E. coli urinary isolates to transmit resistance genes within the plasmid. An analysis of the effectiveness of conjugation has shown that E. coli strains producing ESBL are capable of transferring resistance genes to a recipient bacterium at a high frequency

    The synaptic ribbon is critical for sound encoding at high rates and with temporal precision.

    No full text
    We studied the role of the synaptic ribbon for sound encoding at the synapses between inner hair cells (IHCs) and spiral ganglion neurons (SGNs) in mice lacking RIBEYE (RBEKO/KO). Electron and immunofluorescence microscopy revealed a lack of synaptic ribbons and an assembly of several small active zones (AZs) at each synaptic contact. Spontaneous and sound-evoked firing rates of SGNs and their compound action potential were reduced, indicating impaired transmission at ribbonless IHC-SGN synapses. The temporal precision of sound encoding was impaired and the recovery of SGN-firing from adaptation indicated slowed synaptic vesicle (SV) replenishment. Activation of Ca2+-channels was shifted to more depolarized potentials and exocytosis was reduced for weak depolarizations. Presynaptic Ca2+-signals showed a broader spread, compatible with the altered Ca2+-channel clustering observed by super-resolution immunofluorescence microscopy. We postulate that RIBEYE disruption is partially compensated by multi-AZ organization. The remaining synaptic deficit indicates ribbon function in SV-replenishment and Ca2+-channel regulation

    Legislation On The Preparation Of Medicinal Products In European Pharmacies And The Council Of Europe Resolution

    Get PDF
    The rights of patients should be sufficiently protected even when an appropriate authorised medicine does not exist or is unavailable on the market. The Resolution, which was adopted by the Committee of Ministers of the Council of Europe in 2011, aims at harmonising quality and safety standards for pharmacy preparation of medicinal products in Europe.Two pillars of EU regulation and the exceptions to them The system of regulation of medicinal products is built upon two pillars: the marketing authorisation of the medicinal product and the licence for manufacturing and wholesale. This article provides insight into the recent interpretation of the European Court of Justice concerning the scope of European Union (EU) regulation of medicinal products and the circumstances in which the EU regulation does not apply: pharmacy preparations, specialties and the compassionate use of medicines, including manufacturing licence.EU regulation and the Resolution concerning pharmacy preparation Pharmacy preparations are allowed under certain strict conditions according to EU regulations. However, pharmacies specialised in preparation and distributing medicinal products to local pharmacies do not fulfil these strict conditions in EU regulation. Apart from the legal context, relevant standards for safety and quality assurance are needed in Europe in order to protect patients’ rights and to avoid risks from pharmacy preparations.Discussion and conclusions The Council of Europe Resolution provides a means of establishing standards for safety and quality assurance for pharmacy preparations through Good Manufacturing Practice Guidelines. The Resolution is available to authorities and pharmacists in order to prevent incidents with medicines prepared in pharmacies which may threaten patients’ safety. The authors conclude that pharmacy practices have changed over time in Europe and this may imply a reason for a reform of EU regulation on medicinal products
    corecore